Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2019

Feb 26, 2019

29821_dirs_2019-02-26_c94548fc-3182-4a95-a165-143f61c1206c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2019-02-22

Reporting Person: Mackey Edward F (EVP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-22 Common Stock M 2897.0000 $0.0000 Acquired 106317.0000 Direct
2019-02-22 Common Stock F 1288.0000 $40.5200 Disposed 105029.0000 Direct
2019-02-23 Common Stock M 2299.0000 $0.0000 Acquired 107328.0000 Direct
2019-02-23 Common Stock F 1022.0000 $40.5200 Disposed 106306.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-22 Deferred Stock Units $ M 2897.0000 Disposed 2021-02-22 Common Stock (2897.0000) Direct
2019-02-23 Deferred Stock Units $ M 2299.0000 Disposed 2020-02-23 Common Stock (2299.0000) Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

F3: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.